September 2026
The global live biotherapeutic products and microbiome CDMO market size is estimated to hit around USD 1,838.56 million by 2035 from USD 106.79 million in 2026, at a CAGR of 37.38%.
September 2025
The global microbiome manufacturing market size is estimated to hit around USD 130.37 billion by 2034 increasing from USD 26.98 billion in 2024, with a CAGR of 17.06%.
July 2026
The global ophthalmic drug CDMO market expands with advancements in drug delivery systems and rising prevalence of chronic eye diseases globally.
September 2026
The global landscaping products market size reached USD 100.93 billion in 2026 and is projected to surpass around USD 170.46 billion by 2034, with a notable CAGR of 6.76%.
September 2026
The global veterinary CRO and CDMO market size was valued at USD 8.38 billion in 2026 and is predicted to surpass around USD 17.15 billion by 2035 with a CAGR of 8.30%.
September 2026
The global drug and gene delivery devices market size is projected to hit around USD 1,875.96 million by 2035 from USD 864.96 million in 2026, with a CAGR of 9.00%.
September 2026
The global essential oils and plant extract for livestock market size is estimated to hit around USD 5.61 billion by 2035 increasing from USD 3.27 billion in 2026, with a CAGR of 6.18%.
September 2026
The global livestock and meat market size is estimated to hit around USD 1.63 trillion by 2035 increasing from USD 1.41 Trillion in 2026, with a CAGR of 1.61%.
September 2026
The global insulin drugs and delivery devices market size is evaluated at USD 27.47 billion in 2026 and is predicted to hit around USD 52.72 billion by 2035, growing at a CAGR of 7.52%.
September 2026
The cancer therapeutics and biotherapeutics market size reached USD 228.73 billion in 2026, with leading cancer therapeutics and biotherapeutics market companies including Amgen Inc., Bristol-Myers Squibb, Celgene Corporation.
July 2026
The global home rehabilitation products and services market size is projected to hit around USD 284.86 billion by 2035 from USD 150.97 billion in 2025 and with a CAGR of 6.56%
July 2026
The global beauty and personal care products market size is expected to hit around USD 1151.25 billion by 2034 from USD 639.47 billion in 2025 with a CAGR of 6.76%.
July 2026
The cell and gene therapy market established a strong position in 2026 and is projected to expand significantly from 2026 through 2035, driven by increasing demand, evolving market needs, technological advancements, and growing adoption across key industries.
June 2026
The global laboratory products and outsourcing services market size is estimated at USD 45.23 billion in 2026 and is expected to hit around USD 91.45 billion by 2035, growing at a CAGR of 8.15%
January 2026
The global plug-and-play CDMO market is growing rapidly as pharma and biotech firms seek flexible, scalable, and fast-track manufacturing solutions.
July 2025
The global cell and gene therapy CDMO market size is estimated to hit around USD 74.03 billion by 2034 increasing from USD 10.33 billion in 2026, with a CAGR of 27.92%.
July 2025
The global personal care CMO and CDMO market size reached USD 28.02 billion in 2024 and is projected to surpass around USD 44.86 billion by 2034 with a CAGR of 4.82%.
September 2026
The injectable drug delivery market reached USD 829.98 billion in 2026, with prominent companies such as Sandoz, therumo, schott ag, gerresheimer, ypsormed leading the injectable drug delivery market.
September 2026
The insulin delivery devices market size reached USD 22.50 billion in 2026, with leading insulin delivery devices market companies including Novo Nordisk A/S, Wockhardt Ltd., Medtronic.
September 2026
The advanced drug delivery market size is calculated at USD 103.84 billion in 2026 and is projected to hit around USD 371.83 billion by 2035 with a CAGR of 15.26%.
September 2026
The microbial products market size was USD 232.49 billion in 2026, with leading microbial products market players including merck kgaa, sumitomo biorational company, lallemand inc, basf se, Bayer cropscience.
September 2026
The global meal replacement products market size is accounted to hit around USD 55.74 billion by 2035 increasing from USD 27.61 billion in 2026, with a CAGR of 8.13%.
September 2026
The global livestream e-commerce market size is projected to surpass around USD 312.35 billion by 2035 increasing from USD 26.41 billion in 2026, with a CAGR of 31.72%.
September 2026
The liver cancer drug market was valued at USD 5.19 billion in 2026, with leading companies including Bayer AG, Bristol Myers Squibb.
September 2026
The global gastro-retentive drug delivery systems outsourcing market size is expected to increase from USD 2.17 billion in 2026 to hit around USD 3.86 billion by 2035, growing at a CAGR of 6.58%.
September 2026
The global vaccine delivery devices market size was evaluated at USD 8.69 billion in 2026 and is predicted to hit around USD 17.10 billion by 2035, growing at a CAGR of 7.81%.
September 2026
The global exosome-based cancer therapy CDMO market is growing as demand rises for scalable manufacturing and delivery solutions in exosome therapeutics.
September 2026
The RNA interference drug delivery market was worth USD 139.58 billion in 2026, with key RNA interference drug delivery market players including Dicerna Pharmaceuticals (Acquired by Novo Nordisk), Silence Therapeutics, Ionis Pharmaceuticals.
September 2026
The global bispecific antibodies CDMO market expands with demand for next-generation therapeutics, advanced expression systems, and regulatory compliance expertise.
September 2026
The antihyperlipidemic market is valued at USD 15.02 billion in 2025 and is expected to expand at a CAGR of 5.64% during the forecast period. Research by Deepa Pandey, Senior Research Analyst.
+1 650 460 3308
+61 485 981 310 +91 87933 22019
sales@precedenceresearch.com